YKL-40 can be assumed as s persuasive biomarker of diagnosis, prognosis, disease severity and activity in certain diseases, e.g. AP, chronic liver disease, AAV, RA, PA, COPD and sepsis. This evidence concerns the gene CHI3L1 and alkaline phosphatase measurement.